Sinagarepharmaceuticals (Opc) Private Limited - Company Profile

It is a chemicals enterprise based in Pune, Maharashtra, India, established in 2020.
2020 Pune, Maharashtra, India Struck Off
Last Updated:
Access Report
About Sinagarepharmaceuticals (Opc) Private Limited

Sinagarepharmaceuticals (Opc) Private Limited, Engaging in other chemical product within the chemicals sector, it holds CIN: U24290PN2020OPC196528. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹10.00 K .

Its leadership includes Sambhaji Dattatray Singare (Nominee), Sagar Sambhaji Shingare (Director). It is based at C/Oshrigorakhshankarmangadepushpaemerald Wing A Shop No 1 S No 75 1 2 3 4 Nr, Pune, Maharashtra, 411046.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24290PN2020OPC196528

  • Registration Number

    196528

  • Incorporation Date

    03 December 2020

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹10.00 K

  • ROC Code

    Roc Pune

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 10.00 K
  • Company Age 5 Year, 2 Months
Company report

Sinagarepharmaceuticals (Opc) Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Sinagarepharmaceuticals (Opc) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Sinagarepharmaceuticals (Opc) Private Limited?
Current Directors
Name Designation Appointment Date Status
Sambhaji Dattatray Singare Nominee 03 Dec 2020 Current
Sagar Sambhaji Shingare Director 03 Dec 2020 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Sinagarepharmaceuticals (Opc).

Enhance accessibility to Sinagarepharmaceuticals (Opc)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Sinagarepharmaceuticals (Opc) revenue growth over time
Sinagarepharmaceuticals (Opc) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Sinagarepharmaceuticals (Opc)?

Unlock access to Sinagarepharmaceuticals (Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Sinagarepharmaceuticals (Opc)?

Sinagarepharmaceuticals (Opc) has a workforce of 0 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Sinagarepharmaceuticals (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sinagarepharmaceuticals (Opc)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Sinagarepharmaceuticals (Opc)
Recent Activity within the Organization
  • Director Appointment

    The activity Sambhaji Dattatray Singare was appointed as a Nominee was appointed as a Nominee on 03 Dec 2020 & has been associated with this company since 5 years 2 months . was completed.

  • Director Appointment

    The activity Sagar Sambhaji Shingare was appointed as a Director was appointed as a Director on 03 Dec 2020 & has been associated with this company since 5 years 2 months . was completed.

  • Company Incorporation

    Progress on Sinagarepharmaceuticals (Opc) Private Limited was registered on 03 Dec 2020 with Roc Pune & aged 5 years 2 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Sinagarepharmaceuticals (Opc) Private Limited?

The CIN of Sinagarepharmaceuticals (Opc) Private Limited is U24290PN2020OPC196528.

Where is Sinagarepharmaceuticals (Opc) Private Limited headquartered?

Sinagarepharmaceuticals (Opc) Private Limited is headquartered at C/Oshrigorakhshankarmangadepushpaemerald Wing A Shop No 1 S No 75 1 2 3 4 Nr, Pune, Maharashtra, 411046.

When was Sinagarepharmaceuticals (Opc) Private Limited incorporated?

Sinagarepharmaceuticals (Opc) Private Limited was incorporated on 03 December 2020.

Who are the current directors of Sinagarepharmaceuticals (Opc) Private Limited?

The current directors of Sinagarepharmaceuticals (Opc) Private Limited are

What is the primary industry of Sinagarepharmaceuticals (Opc) Private Limited?

The primary industry of Sinagarepharmaceuticals (Opc) Private Limited is Chemicals.

Is Sinagarepharmaceuticals (Opc) Private Limited a listed company?

Sinagarepharmaceuticals (Opc) Private Limited is unlisted.

What is the capital structure of Sinagarepharmaceuticals (Opc) Private Limited?

The authorized capital of Sinagarepharmaceuticals (Opc) Private Limited is ₹1.00 M, and the paid-up capital is ₹10.00 K .

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available